Pancreatitis Trial, Recruiting NCT07508930 Sponsor: Russian Cardiology Research and Production Center Condition: Pancreatitis
Back to Pancreatitis

Pancreatitis Trial, Recruiting

NCT07508930
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have very high triglyceride (a type of fat) levels in their blood — specifically at or above 10 mmol/L — confirmed by at least two separate blood tests.
  • People of any age may be considered, as there are no age restrictions.
  • Written agreement to take part in the trial must be provided by the patient or, where needed, their legal guardian.

Who may not be able to join:

  • People whose very high triglyceride levels appear to be caused by heavy alcohol use, poorly managed diabetes, or other medical conditions — unless those underlying conditions have been brought under control and the high triglyceride levels are still confirmed afterwards (confirm with trial site).
  • People who have not provided written agreement to participate in the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marat Ezhov, MD, PhD

Phone: +7 495 414-6067

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Russian Cardiology Research and Production Center
Registry
ClinicalTrials.gov
Start date
20 November 2025
Est. completion
1 December 2045

Where this trial is recruiting

🇷🇺 Russia

Primary endpoints

Mortality (all-cause and cardiovascular)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov